Scientists have identified unique "indicators" in the blood of patients with severe and fatal COVID, paving the way for simple diagnostic tests to help doctors identify who will go on to become critically ill.
Dec 21, 2021
0
715
A new study has shown how SARS-CoV-2 may contribute to severe microvascular damage seen in severely-ill COVID-19 patients by transforming human heart vascular cells into inflammatory cells, without infecting them. The University ...
Feb 3, 2022
2
205
In patients with serious and long-term COVID-19, disturbed blood coagulation has often been observed. Now, researchers at Linköping University (LiU), Sweden, have discovered that the body's immune system can affect the spike ...
May 19, 2022
0
761
Heart damage is common among patients hospitalized with COVID-19, leading many to wonder how the virus affects the heart. Now, researchers have found that the spike protein from the severe acute respiratory syndrome coronavirus ...
Jul 25, 2022
0
390
A new UCLA study could change scientists' understanding of how the brain works—and could lead to new approaches for treating neurological disorders and for developing computers that "think" more like humans.
Mar 9, 2017
1
4251
An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses ...
Dec 27, 2021
0
1273
Most research on immunity to the SARS-CoV-2 virus and COVID-19 vaccine development has focused on antibody responses to the spike protein and other viral surface proteins. But antibodies that recognize the virus's internal ...
Jun 24, 2022
0
154
The quickly changing coronavirus has spawned yet another super contagious omicron mutant that's worrying scientists as it gains ground in India and pops up in numerous other countries, including the United States.
Jul 11, 2022
0
154
Scientists at Lausanne University Hospital (CHUV) and EPFL have discovered a highly potent monoclonal antibody that targets the SARS-CoV-2 spike protein and is effective at neutralizing all variants of concern identified ...
Oct 12, 2021
0
1309
When looking at the state of COVID-19 in the United States, Mansoor Amiji, distinguished professor in the Department of Pharmaceutical Sciences at Northeastern, invites you to think from the perspective of a virus. What does ...
Jun 10, 2022
0
53
